Substance Use Disorders Clinical Trial
Official title:
The Canadian Underage Substance Use Prevention Trial
Despite having made some strides with respect to reducing adolescent drinking rates, illicit substance use and substance use disorders (SUDs) remain significantly above national targets for health promotion and disease prevention in Canada and the United States. Now, more than ever, there is a pressing need for effective substance abuse prevention in Canada, particularly for those most at risk of developing substance use problems including prescription drug misuse. Clearly, new approaches to prevention (with lower numbers needed to treat) are needed and which translate new research on addiction vulnerability to personalised prevention and early intervention. The PreVenture Program involves brief cognitive-behavioural interventions targeting personality traits from a neurocognitive perspective. While the personality-targeted approach has been shown to be effective in reducing most substance use behaviors, it has yet to be evaluated for its impact on uptake of prescription drug misuse in adolescents. The Canadian Underage Substance use Prevention (CUSP) Trial aims to evaluate the long-term effects of a personality-targeted school-based prevention program on delaying the onset of drug and alcohol use in adolescence over three years across Canada. This is a hybrid effectiveness [E] and implementation-facilitation [IF] trial on delaying the onset of drug and alcohol use in adolescence. In the [E] part, the effects of a personalized prevention program will be tested against usual school-based prevention curricula. PreVenture is delivered through a TtT implementation model with or without [IF], e.g. with ongoing supervision and web-based support. The [IF] package is designed to support long-term sustainability of PreVenture after a community accesses PreVenture training.
Aim:
To evaluate the long-term effects of the PreVenture program on delaying the onset of drug and
alcohol use in adolescence when delivered through a train-the-trainer (TtT) implementation
model.
Questions:
This is a hybrid effectiveness [E] and implementation-facilitation [IF] trial on delaying the
onset of drug and alcohol use in adolescence. In the [E] part, the effects of a personalized
prevention program will be tested against usual school-based prevention curricula. PreVenture
is delivered through a TtT implementation model with or without [IF], e.g. with ongoing
supervision and web-based support. The [IF] package is designed to support long-term
sustainability of PreVenture after a community accesses PreVenture training.
[E] questions: Does the personalized intervention delay the onset and reduce the severity of
problem substance use among secondary school students when schools are trained through a TtT
model (primary)? Does the intervention impact the onset and frequency of binge drinking,
cannabis and illicit drug use, and uptake of non-medical prescription drug use at (i) one
year and (ii) two years post-intervention (secondary)? What are the factors which impact the
delay of onset and reduction of severity?
[IF] questions: What are the best conditions under which the program implementation is
sustained to a high quality from one year to the next? What are the costs and potential
economic benefits of the intervention with and without additional implementation
facilitation?
Design:
Three sites (NS; ON; BC) will participate in the trial. Each site will recruit 9 high schools
randomized to one of three intervention conditions:
1. Treatment-As-Usual (TAU) control: standard curriculum and mental health care
2. TtT PreVenture delivered through local trainers (PTtT): Each site will identify two
Trainers to be trained to deliver high fidelity PreVenture training to 4 school-based
professionals per school assigned to this condition and condition 3 (see below). Each
school will identify the 4 staff members to receive training and administer practice
sessions using structured manuals with assessment of quality of the interventions.
3. TtT PreVenture with Implementation Facilitation (PTtT+IF): three new components designed
to increase the likelihood that schools will continue to implement the program with high
quality and satisfaction: a) Involvement of youth in promoting the program, b) ongoing
coaching/supervision sessions for group facilitators, c) access to easy-to-use
performance metrics.
Each school will screen all assenting grade 10 students (N=150 per school) in 2019 (Cohort 2
followed up until 2021), 2020 (Cohort 3 followed up until 2021) and 2021 (Cohort 4 no
follow-up), which will result in approximately 4,050 students screened across 27 schools in
Canada each year totaling 12,150 students over 3 years. [Cohort 1 is training-only in 2018]
All 4050 students will be invited to participate in the trial each year and will be followed
annually to facilitate coordination of assessments at the school level and to reduce any
stigma to targeted youth. Youth who assent to being randomized to an intervention condition
and who score above the personality threshold will be considered the Intent-to-Treat [ITT]
sample, regardless of whether or not the school managed to deliver the intervention. The
whole grade will be followed to assess secondary outcomes at the whole grade level as
reported in Conrod et al, 2013.
The PreVenture program is a personality targeted prevention program designed to help youth
understand the target personality trait and develop adaptive coping strategies for managing
that trait using motivational and cognitive restructuring techniques. Four
personality-specific motivational pathways to substance misuse are targeted hopelessness
(HOP), anxiety sensitivity (AS), impulsivity (IMP) and sensation seeking (SS). PreVenture
involves 2 90-minute group sessions, with one week separating each session. The interventions
are conducted using structured manuals that incorporate psycho-educational, motivational
enhancement (MET), and cognitive-behavioural (CBT) therapy components, and include real life
'scenarios' shared by local youth with similar personality profiles.
Main Hypotheses:
[E] primary outcome: PreVenture will result in less severity of substance use problems as
measured by the CRAFFT score after 12- and 24-month follow-up (comparison of both arms with
PreVenture against treatment as usual using Cohort 2 in all three conditions)
[E] secondary outcome: PreVenture will result in lower prevalence of binge drinking, lowered
frequency of cannabis use, other illicit drug use and non-medical prescription drug use after
12- and 24-month follow-ups (comparison of both arms with PreVenture against treatment as
usual using Cohort 2 in all three conditions)
[IF] primary outcome: In the PreVenture group with implementation-facilitation, the rate of
successful interventions (less severity on CRAFFT score) after 12-month follow-up is higher
than in the PreVenture group without implementation-facilitation (comparison of 12-month
results of Cohort 3 between both conditions)
[IF] secondary outcome: In the PreVenture group with implementation-facilitation, the rate of
interventions in Year 4 after the start of PreVenture interventions is higher than in the
PreVenture group without implementation-facilitation (comparison of Cohort 4 between both
conditions)
Data analyses strategy for [E]:
The core data for exploring effectiveness will be in Cohort 2, followed up for 24 months.
This allows for the use of growth models, which can model intra-individual change over time.
The dependent variables for these models change, may be dichotomous (e.g., onset of substance
use: yes/no), ordinal, expressing counts or have interval properties (for example, the CRAFFT
scale can be used as an ordinal or count variable - i.e. this poses a number of problems -
but has also been used as a scale with interval scale properties). Different scale types
require different types of regression analyses to be used in growth modelling (i.e., linear
regression, logistic regression, Poisson regression, etc.).
For the CRAFFT score, three aspects require consideration:
1. proportion of people with 0 values, i.e., no onset of substance use or no problems
2. left-hand censoring, as values cannot be lower than 0
3. assumption that the change from 0 to 1 is a structurally different change than the
changes involving values greater or equal to 1 The first problem can be dealt with by
using specific models for zero inflation, which started with zero-inflated Poisson
distributions, but by now has been extended to most forms of regression analyses.
Censoring should not be a problem as the investigators are dealing with increasing
slopes, and will treat the CRAFFT as a count variable, which by definition has 0 as
starting values. As for structural changes between the transition from 0 to 1 vs. other
changes, the investigators will explore via the Heckman model, which will model the
transition from 0 to 1 separately, allowing for different influence factors.
For the primary outcome, the following statistical procedures will be used (ITT analyses):
- Dependent variable: CRAFFT score
- Regression type used for growth modelling: zero-inflated Poisson regression
- Adjustment variables: sex, age, province
- Relevant statistics: adjusted CRAFFT score after combined 12- and 24-month follow-up of
combined PreVenture groups vs. treatment as usual (TAU) group.
For the secondary hypotheses, similar procedures will be used, with the specific regression
type to be determined by the dependent variable. In addition to ITT analyses, sensitivity
analyses with different assumptions on missing values will be conducted. The investigators
will also test if the effect of PreVenture is significant in each of the two time points
(i.e., not only for the combined time points).
Other analyses will explore different influencing factors on the effectiveness of PreVenture
and these analyses will be conducted in the same framework, adding different independent
variables. The investigators will combine this framework with a latent framework (latent
growth analyses); to separate groups with different trajectories, and will model influences
on these separate trajectories.
Data analysis strategy for [IF]:
It is important for an intervention such as PreVenture, which has proven efficacy under
certain conditions, to show effectiveness in the real world under less optimal conditions,
and to measure the various impacts on effectiveness. Accordingly, one of the experimental
conditions systematically varies implementation conditions by introducing three additional
components: a) Involvement of local youth in promoting the program, b) ongoing
coaching/supervision sessions for group facilitators, c) access to easy-to-use performance
metrics.
The impact of facilitation will be tested in the following primary implementation hypothesis:
- Dependent variable: rate of implemented interventions
- Regression type used for growth modelling: fractional response regression
- Adjustment variables: sex, age, province
- Relevant statistics: adjusted rates of implementations at the 12-month follow-up between
the two PreVenture groups (with vs. without implementation-facilitation) The alternative
hypotheses will be accepted, if the PreVenture group with implementation-facilitation
has a higher rate.
There will be more analyses to explore the implementation facilitation. One key will be
measurement of the fidelity and quality of implementation, and the investigators will be
using a specifically developed measure, the PreVenture Intervention Fidelity and Adherence
(PIFA) scale, for the latter.
Overall, the analyses will include the infrastructure, the number of interventions produced,
and the success rates of these interventions.
Economic considerations:
- For (IF), a cost-utility analysis of the two PreVenture conditions to determine the
incremental cost-utility ratio per improvements of the Child Health Utility (CHU9D)
scale (based on the primary hypothesis in [IF]) will be conducted. Analyses can be
widened to include comparisons between TAU and PreVenture conditions.
- Alternatively, a cost-benefit analysis on the impact of PreVenture from a societal cost
perspective could also be conducted. The costs of the implementation would then be
compared to cost-savings in resources necessary to cope with the substance use problems,
where the latter could either be derived from the literature, and/or from a subsample
analysis for health and judicial service utilization.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05660434 -
Using Aromatherapy in Substance Use Disorder
|
N/A | |
Active, not recruiting |
NCT05338268 -
Substance Use and Loneliness
|
N/A | |
Completed |
NCT03954184 -
E-health Implementation (Iowa)
|
N/A | |
Completed |
NCT04098614 -
Barriers to Substance Use Disorder Recovery
|
N/A | |
Completed |
NCT03590106 -
Cardiac Surgery Peer Recovery Support Program
|
N/A | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Recruiting |
NCT06273228 -
Parenting Young Children in Pediatrics
|
N/A | |
Recruiting |
NCT05327504 -
Written Exposure Therapy for Veterans With SUD and PTSD
|
N/A | |
Terminated |
NCT03517111 -
The Impact of a Parenting Intervention on Latino Youth Health Behaviors
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT04401215 -
Technologically-Augmented Referrals to Mitigate Addiction Consequences
|
N/A | |
Not yet recruiting |
NCT06187701 -
Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients
|
N/A | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Active, not recruiting |
NCT02382042 -
Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans
|
N/A | |
Terminated |
NCT01356667 -
Drum-Assisted Therapy for Native Americans
|
N/A | |
Completed |
NCT01237366 -
Study Targeting Affect Regulation
|
Phase 1/Phase 2 | |
Completed |
NCT00708890 -
Twelve Step Based Self-help Groups for Substance Related Disorders
|
N/A | |
Active, not recruiting |
NCT04048850 -
Zepatier in Patients With Substance Use
|
||
Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 |